The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Lymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis
Abstract
Objective Immunohistochemical examination was undertaken to assess the presence of lymphocytes and lymphocyte subsets in the spinal cord in amyotrophic lateral sclerosis (ALS). Design Twenty-seven consecutive ALS autopsy cases and 11 consecutive disease--control autopsy cases were examined. Tissue sections were reacted with mouse monoclonal antibody to human leukocyte common antigen, or monoclonal antibody to human B-cell L26 antigen, and detected with immunoperoxidase techniques. Unfixed sections were reacted with antihuman Leu-3a and Leu-3b/CD4 or antihuman Leu-2a/CD8 mouse monoclonal antibody and then detected with peroxidase techniques. Setting Tertiary care hospital. Cases Amyotrophic lateral sclerosis and non-ALS control autopsy specimens. Main outcome measure Detection of lymphocytes by histological and immunohistochemical reactivity. Results Perivascular and intraparenchymal lymphocytic infiltrates were found in the spinal cord of 18 of 27 consecutive ALS autopsy cases. The lymphocytes possessed only T-cell markers; no B-cell markers could be demonstrated. T-helper cells were found in proximity to degenerating corticospinal tracts, while T-helper and T-suppressor/cytotoxic cells were demonstrated in ventral horns. Lymphocytes were present in the spinal cord of only one control specimen (multiple sclerosis) and in none of the remaining 10 control specimens. In ALS tissue, the lymphocytic infiltrates did not correlate with the rate of progression or stage of the disease…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings support earlier observations showing that the BBB and BSCB are damaged in a subset of ALS patients as demonstrated by accumulation of plasma-derived IgG in the spinal cord and motor cortex in 40% (154) to 90% (163) of studied cases, and accumulation of peripheral blood cells in 70% (164) to 100% (599) of studied cases.”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [164]
Citations
Cites
Somogyi, P., & Takagi, H. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90035-5 · Cited by 572
Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue.
Kawamata, T., Akiyama, H., Yamada, T., & McGeer, P. L. (1992) · PubMed Central · Cited by 546
Expression of the histocompatibility glycoprotein HLA-DR in neurological disease
McGeer, P. L., Itagaki, S., & McGeer, E. G. (1988) · Acta Neuropathologica · doi:10.1007/bf00689592 · Cited by 420
Diagnosis of Human Lymphoma with Monoclonal Antileukocyte Antibodies
Warnke, R. A., Gatter, K. C., Falini, B., Hildreth, P. D. K., Woolston, R.-E., Pulford, K. A. F., Cordell, J., Cohen, B., Wolf‐Peeters, C. D., & Mason, D. Y. (1983) · New England Journal of Medicine · doi:10.1056/nejm198311243092102 · Cited by 366
Engleman, E. G., Benike, C. J., Glickman, E., & Evans, R. L. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.154.1.193 · Cited by 301
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221
Self-citationSerum antibodies to GM 1 ganglioside in amyotrophic lateral sclerosis
Pestronk, A., Adams, R. N., Clawson, L., Cornblath, D. R., Kuncl, R. W., Griffin, D. E., & Drachman, D. B. (1988) · Neurology · doi:10.1212/wnl.38.9.1457 · Cited by 152
Cartun, R. W., Coles, F. B., & Pastuszak, W. (1987) · PubMed · Cited by 139
Lampson, L. A., Kushner, P. D., & Sobel, R. A. (1990) · Annals of Neurology · doi:10.1002/ana.410280311 · Cited by 128
Appel, S. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520030026007 · Cited by 105
Self-citation
Cited by
Sorted by citations
Items 201–300 of 321
Obál, I., Nógrádi, B., Meszlényi, V., Patai, R., Ricken, G., Kovács, G. G., Tripolszki, K., Széll, M., Siklós, L., & Engelhardt, J. I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102573 · Cited by 17
Self-citationGenetic dissection of neurodegeneration and CNS inflammation
Olsson, T. P., Piehl, F., Swanberg, M., & Lidman, O. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.020 · Cited by 17
Ikeda, J., Kohriyama, T., & Nakamura, S. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.t01-1-00114.x · Cited by 17
ALS: Cytokine profile in cerebrospinal fluid T‐cell clones
Holmøy, T., Roos, P. M., & Kvale, E. Ø. (2006) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960600664730 · Cited by 17
Reyes‐Leiva, D., Dols‐Icardo, O., Sirisi, S., Cortés‐Vicente, E., Turón‐Sans, J., de Luna, N., Blesa, R., Belbin, O., Montal, V., Alcolea, D. A., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.750543 · Cited by 18
Immunological Aspects in Amyotrophic Lateral Sclerosis
Oliveira, M. C., Voltarelli, J. C., Sanberg, P. R., Borlongan, C. V., & Garbuzova-Davis, S. N. (2012) · Translational Stroke Research · doi:10.1007/s12975-012-0177-6 · Cited by 16
Alterations in the blood–spinal cord barrier in TDP-43 conditional knockout mice
Sasaki, S., Iguchi, Y., Katsuno, M., & Sobue, G. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.05.005 · Cited by 15
Alarcan, H., Ojaimi, Y. A., Lanznaster, D., Escoffre, J., Corcia, P., Vourc’h, P., Andres, C. R., Veyrat‐Durebex, C., & Blasco, H. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071071 · Cited by 17
Neurodegenerative Disease: Autoimmunity Involving Calcium Channelsa
Appel, S. H., Smith, R., Alexianu, M. E., ENGELHARDT, J., Mosier, D., Colom, L. V., & Stefani, E. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44409.x · Cited by 16
Self-citationShankar, S. K., Gourie‐Devi, M., Shankar, L., Yasha, T. C., Santosh, V., & Das, S. (2000) · Acta Neuropathologica · doi:10.1007/s004010051146 · Cited by 16
Neurovascular dynamics in the spinal cord from development to pathophysiology
de Almodóvar, C. R., Dupraz, S., & Bonanomi, D. (2025) · Neuron · doi:10.1016/j.neuron.2025.09.017 · Cited by 15
Low T-cell reactivity to TDP-43 peptides in ALS
Ramachandran, S., Grozdanov, V., Leins, B., Kandler, K., Witzel, S., Mulaw, M. A., Ludolph, A. C., Weishaupt, J. H., & Danzer, K. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193507 · Cited by 17
Are there immunologically treatable motor neuron diseases?
Nobile‐Orazio, E., Carpo, M., & Meucci, N. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/167-146608201300079382 · Cited by 15
Sheean, R. K., Weston, R. H., Perera, N. D., D’Amico, A., Nutt, S. L., & Turner, B. J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0254-3 · Cited by 15
Hiew, J. Y., Lim, Y.-B., Liu, H., & Ng, C. S. (2025) · Communications Biology · doi:10.1038/s42003-025-07790-w · Cited by 18
Hermitte, L., Martin‐Moutôt, N., Boucraut, J., Barone, R., Atlan-Gepner, C., SEAGAR, M. J., Pouget, J., Kleisbauer, J. P., Couraud, F., & Vialettes, B. (2000) · Journal of Clinical Immunology · doi:10.1023/a:1006619820040 · Cited by 14
Ford, L. S., & Rowe, D. B. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410019125 · Cited by 14
Walther, M. R., Popratiloff, A. S., Lachnit, N., Hofmann, N., Streppel, M., Guntinas‐Lichius, O., Neiss, W. F., & Angelov, D. N. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00302-2 · Cited by 14
Association between ALS and retroviruses: evidence from bioinformatics analysis
Klein, J. P., Sun, Z., & Staff, N. P. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-3249-8 · Cited by 13
Caioli, S., Pieri, M., Antonini, A., Guglielmotti, A., Severini, C., & Zona, C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.045 · Cited by 14
The Role of TNF-Alpha in ALS: New Hypotheses for Future Therapeutic Approaches
Cereda, C., Gagliardi, S., Cova, E., Diamanti, L., & Ceroni, M. (2012) · InTech eBooks · doi:10.5772/31223 · Cited by 14
Baumert, B., Sobuś, A., Gołąb-Janowska, M., Paczkowska, E., Łuczkowska, K., Rogińska, D., Zawiślak, A., Milczarek, S., Osękowska, B., Pawlukowska, W., et al. (2020) · Cells · doi:10.3390/cells9081822 · Cited by 12
Perrin, S., Ladha, S. S., Maragakis, N. J., Rivner, M. H., Katz, J., Genge, A. L., Olney, N. T., Lange, D. J., Heitzman, D., Bodkin, C. L., et al. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004469 · Cited by 11
Self-citationLoss of CREST leads to neuroinflammatory responses and ALS-like motor defects in mice
Cheng, C., Yang, K., Wu, X., Zhang, Y., Shan, S., Gitler, A. D., Ghosh, A., & Qiu, Z. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0152-1 · Cited by 11
Kobashi, S., Terashima, T., Katagi, M., Urushitani, M., & Kojima, H. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.02.001 · Cited by 10
Amyotrophic Lateral Sclerosis Associated with Sarcoidosis.
Saiki, S., Yoshioka, A., Yamaya, Y., & Hirose, G. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.822 · Cited by 10
Altered muscle calcium channel binding kinetics in autoimmune motoneuron disease
Smith, R. G., Kimura, F., Harati, Y., McKinley, K. L., Stefani, E., & Appel, S. H. (1995) · Muscle & Nerve · doi:10.1002/mus.880180609 · Cited by 10
Self-citationCausal ALS genes impact the MHC class II antigen presentation pathway
Chi, B., Öztürk, M. M., Paraggio, C. L., Leonard, C. E., Sanita, M. E., Dastpak, M., O’Connell, J. D., Coady, J. A., Zhang, J., Gygi, S. P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2305756120 · Cited by 8
Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis
Amor, S., Nutma, E., Marzin, M. C., & Puentes, F. (2021) · Clinical & Experimental Immunology · doi:10.1111/cei.13660 · Cited by 9
Appel, S. H., Engelhardt, J. I., Smith, R. G., & Stefani, E. (1995) · Springer eBooks · doi:10.1007/978-1-4471-1871-8_11 · Cited by 9
Self-citationThe Role of Microglial Cells in Amyotrophic Lateral Sclerosis
Weydt, P., & Möller, T. (2005) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2005.08.021 · Cited by 10
Willekens, S. M. A., Weehaeghe, D. V., Damme, P. V., & Laere, K. V. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3587-y · Cited by 9
Emerging role of neural stem/progenitor cell secretome in brain inflammatory response modulation
Łukowicz, K., Grygier, B., & Basta‐Kaim, A. (2025) · Pharmacological Reports · doi:10.1007/s43440-025-00733-6 · Cited by 8
Jovanova-Nešić, K., & Shoenfeld, Y. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.016 · Cited by 3
Mariotti, R., Tongiorgi, E., Bressan, C., Armellin, M., Kristensson, K., & Bentivoglio, M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01507.x · Cited by 8
Allogeneic B cell immunomodulatory therapy in amyotrophic lateral sclerosis
Sîrbulescu, R. F., Nicholson, K. A., Kawai, K., Hilton, O., Sobell, D., Jin, G., Verrill, D. E., Dwyer, L., Xiong, Y., Bachanová, P., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302659r · Cited by 7
Matsuo, K., Nagamatsu, J., Nagata, K., Umeda, R., Shiota, T., Morimoto, S., Suzuki, N., Aoki, M., Okano, H., Nakamori, M., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1357204 · Cited by 8
Wannemacher, R., Reiß, A., Röhn, K., Lühder, F., Flügel, A., Baumgärtner, W., & Hülskötter, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1194842 · Cited by 8
Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals
Edri‐Brami, M., Sharoni, H., Hayoun, D., Skutelsky, L., Nemirovsky, A., Porgador, A., & Lichtenstein, R. G. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.023 · Cited by 7
Mazzucca, C. B., Cappellano, G., & Chiocchetti, A. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230502123255 · Cited by 7
Chen, S., Huan, X., Xu, C., Luo, S., Zhao, C., Zhong, H., Zheng, X., Qiao, K., Dong, Y., Wang, Y., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14503 · Cited by 6
Glial Cells in ALS: The Missing Link?
Raibon, E., Todd, L. M., & Möller, T. (2008) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2008.04.003 · Cited by 8
Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study
Hu, Z., Zuo, C., Mao, C., Changhe, S., & Xu, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1269354 · Cited by 6
Monsour, M., Garbuzova-Davis, S. N., & Borlongan, C. V. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac072 · Cited by 6
Ramalho, T. C., de Castro, A. A., Tavares, T. S., Silva, M. D. C., Silva, D. R., Cesar, P. H., Santos, L. D. A., da Cunha, E. F. F., Nepovimová, E., & Kuča, K. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.06.011 · Cited by 6
Motoneurons and CD4+ effector T cell subsets: Neuroprotection and repair
Byram, S. C., Serpe, C. J., DeBoy, C. A., Sanders, V. M., & Jones, K. J. (2006) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2006.06.001 · Cited by 6
Serum soluble OX40 in patients with amyotrophic lateral sclerosis.
Iłżecka, J. (2012) · PubMed · Cited by 6
Montes, J., Bendotti, C., Tortarolo, M., Cheroni, C., Hallak, H., Speiser, Z., Goren, S., Blaugrund, E., & Gordon, P. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00019-9 · Cited by 6
HLA and amyotrophic lateral sclerosis: a systematic review and meta-analysis
Nona, R. J., Greer, J. M., Henderson, R. D., & McCombe, P. (2022) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2022.2078665 · Cited by 5
Disruption of blood-brain barrier in amyotrophic lateral sclerosis: an update
Brylev, L., Zakharova, M. N., Завалишин, И. А., & Gulyaeva, N. V. (2012) · Neurochemical Journal · doi:10.1134/s1819712411040064 · Cited by 5
Leis, A. A., Ross, M. A., Verheijde, J. L., & Leis, J. F. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00012 · Cited by 5
Amyotrophic lateral sclerosis: mechanisms and therapeutic strategies
Bosch, L. V. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00011-7 · Cited by 5
The Neuroinflammation in the Physiopathology of Amyotrophic Lateral Sclerosis
Bowerman, M., Vincent, T., Scamps, F., Camu, W., & Raoul, C. (2013) · InTech eBooks · doi:10.5772/56489 · Cited by 5
Animal Models and Experimental Research in Medicine
Karapehlivan, M., Gelen, V., & Kükürt, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100993 · Cited by 4
Marvulli, R., Megna, M., Romanelli, E., Mastromauro, L., Conte, E., Lancioni, G. E., Dargenio, M., Venuto, G. D., Gallo, G. A., Lerario, R., et al. (2016) · Clinical Immunology Endocrine & Metabolic Drugs · doi:10.2174/2212707003666160810143854 · Cited by 4
Antibodies to L-Type Calcium Channels in Amyotrophic Lateral Sclerosis
Wierzbicki, A. S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305063281818 · Cited by 4
Sligar, C., Sluyter, R., & Ooi, L. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03764-9 · Cited by 3
Zhang, Z., van Olst, L., Alessandrini, F., Wright, M., Edwards, A. J., Boles, J. S., Nalbandian, A., Forsyth, A. V., Shepard, N., Watson, T. H., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02300-5 · Cited by 7
Self-citationNovel therapeutic approaches for motor neuron disease
Muzio, L., Ghirelli, A., Agosta, F., & Martino, G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98817-9.00027-2 · Cited by 3
Adenosine Receptors and Neuroinflammation
Ferrante, A., Simone, R. D., Ajmone‐Cat, M. A., Minghetti, L., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_9 · Cited by 3
Hemizygous Granzyme A Mice Expressing the hSOD1G93A Transgene Show Slightly Extended Lifespan
Moreno‐Martínez, L., Santiago, L., de la Torre, M., Calvo, A. C., Pardo, J., & Osta, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113554 · Cited by 5
Sattler, R., & Rothstein, J. D. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0063 · Cited by 3
Immunological findings in amyotrophic lateral sclerosis
Antel, J. P., & Cashman, N. R. (1996) · Springer eBooks · doi:10.1007/978-3-642-61191-9_3 · Cited by 3
Adaptive immunity in the pathogenesis of neurodegeneration
Li, Y., Ulrich, J. D., & Holtzman, D. M. (2026) · Nature Immunology · doi:10.1038/s41590-026-02538-y · Cited by 4
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
Schirò, G., Stefano, V. D., Iacono, S., Lupica, A., Brighina, F., Monastero, R., & Balistreri, C. R. (2022) · Brain Sciences · doi:10.3390/brainsci12101412 · Cited by 2
The Pathogenesis of Amyotrophic Lateral Sclerosis
Appel, S. H., & SMITH, R. G. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_8 · Cited by 2
Self-citationNeuroinflammation in Neurological Disorders
Kira, J. (2013) · Advances in neurobiology · doi:10.1007/978-1-4614-8313-7_2 · Cited by 2
Eitan, C., Siany, A., Barkan, E., Olender, T., van Eijk, K. R., Moisse, M., Farhan, S. M. K., Danino, Y. M., Yanowski, E., Marmor-Kollet, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.03.446863 · Cited by 2
Lu, T., Luo, L., Yang, J., Cheng, X., & Sun, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04226-0 · Cited by 2
Low CD3 level is a risk factor for amyotrophic lateral sclerosis: a Mendelian randomization study
Yang, W., Liu, X., & Fan, D. (2024) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2024.2407408 · Cited by 1
Immunotherapy for Neurodegenerative Movement Disorders
Mosley, R. L., Saleh, M., & Olson, K. E. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_52 · Cited by 1
ERVK activity in CD8+ T cell immune cell compartment in patients with ALS
Sharma, S., Cortes-Pérez, C. M., Bird, S., Curzio, D. D., Vandenakker, A., Schellenberg, K. L., & Douville, R. N. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03871-7 · Cited by 1
Alkali, N. H., & Pullen, A. H. (2006) · Neurosciences · doi:10.17712/1658-3183.1410 · Cited by 1
Kimura, J. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199738687.003.0022 · Cited by 1
Amyotrophic Lateral Sclerosis: Neurochemical Biomarkers
Verde, F., & Ticozzi, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-06731-0_16 · Cited by 1
Amyotrophic Lateral Sclerosis: A Glial Perspective
Valori, C. F., Brambilla, L., & Rossi, D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0974-2_11 · Cited by 1
Immune-mediated cell death and neuroprotection in neurodegenerative diseases
Appel, S. H., Smith, R. G., & Le, W. D. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50013-8 · Cited by 1
Self-citationNeural Functions of Hematopoietic‐derived Cells
Derecki, N. C., & Kipnis, J. (2013) · Wiley eBooks · doi:10.1002/9781118314814.ch6 · Cited by 1
Ultrastructural evidence of neurofilament involvement in immune-mediated motor neuron injury
Liu, Y., Guo, Y., Xu, L., Wu, S., Wu, D., Yang, C., & Li, C. (2008) · Neurological Research · doi:10.1179/016164108x323780 · Cited by 1
The Role of Regulatory T Cells and Microglia in Amyotrophic Lateral Sclerosis
Beers, D. R., Zhao, W., Hooten, K. G., & Appel, S. H. (2015) · doi:10.1002/9781118732748.ch15
Self-citationCalcium Channel Autoantibodies and Amyotrophic Lateral Sclerosis
Smith, R. G., & Appel, S. H. (1996) · Elsevier eBooks · doi:10.1016/b978-044482383-0/50023-6
Self-citationBehan, P. O., & Chaudhuri, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00007-1
Development of Immunization Approaches to Amyotrophic Lateral Sclerosis
Gros‐Louis, F., Gowing, G., & Julien, J. (2009) · Future Neurology · doi:10.2217/fnl.09.21
On Pathophysiological Mechanisms in Amyothrophic Lateral Sclerosis
Grundström, E. (2000) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Wilson, M. (2011) · D-Scholarship@Pitt (University of Pittsburgh)
Genetic regulation of nerve injury-induced neurodegeneration and inflammation
Swanberg, M. (2007) · Figshare
Notch-1 signaaltransductie en oligodendrocyten dysfunctie in amyotrofe laterale sclerose
Geneeskunde, F., & Wetenschappen, B. (2013)
Sullivan, S. M., Zloković, B. V., & Appel, H. (2013)
Development of a cellular model for C9ORF72-related Amyotrophic Lateral Sclerosis
Stopford, M. J. (2016) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Sattler, R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734916201.793579148
Rodent models of Alzheimer’s disease
Kasza, Á. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9743
Three ALS genes regulate expression of the MHC class II antigen presentation pathwayPreprint
Chi, B., Öztürk, M. M., Paraggio, C. L., Leonard, C. E., Sanita, M. E., Dastpak, M., O’Connell, J. D., Coady, J. A., Zhang, J., Gygi, S. P., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.11.489680
Retinal Disorders in Humans and Experimental ALS Models
Rojas, P., Ramirez, A. I., de Hoz, R., Cadena, M., Salobrar‐García, E., López‐Cuenca, I., Fernández‐Albarral, J. A., Sánchez-Puebla, L., Matamoros, J. A., Salazar, J. J., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.107052
Tuberculin responses after BCG vaccination predict amyotrophic lateral sclerosis risk
Nakken, O., Vaage, A. M., Stigum, H., Heldal, E., Meyer, H. E., & Holmøy, T. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100704 · Cited by 2
Amyotrophic Lateral Sclerosis Involving Gliopathy
Haj-Khlifa, A., Ghachi, H. E., Oukhrib, M., Gamrani, H., & Bouyatas, M. M. (2023) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/978-1-6684-9675-6.ch010
Matsuo, K., Nagata, K., Umeda, R., Shiota, T., Morimoto, S., Suzuki, N., Aoki, M., Okano, H., Nakamori, M., & Nishihara, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.15.575002
Oxisteróis e sua relação com a neuroinflamação na esclerose lateral amiotrófica
Lima, R. S. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2023.tde-12122023-105206
Metadata
- Authors
- Engelhardt, J. I., Tajti, J., & Appel, S. H.
- Affiliations
- Baylor College of Medicine (US)
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1993-01-01
- Volume
- 50
- Issue
- 1
- Pages
- 30-36
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2069781018
- Cited by
- 318
- References
- 25
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 14 · 2023: 19 · 2022: 20 · 2021: 10 · 2020: 16 · 2019: 14 · 2018: 15 · 2017: 11 · 2016: 12 · 2015: 14 · 2014: 10 · 2013: 14 · 2012: 19
- FWCI
- 5.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- amyotrophic lateral sclerosis, spinal cord, lymphocyte infiltration, T cells, T helper cells, suppressor/cytotoxic T cells, corticospinal tract degeneration, ventral horn, B cells, CD45, CD4, CD8, neuroinflammation
- MeSH terms
- Adult, Aged, Amyotrophic Lateral Sclerosis, B-Lymphocytes, Female, Humans, Male, Middle Aged, Spinal Cord, CD4-Positive T-Lymphocytes, CD4 Antigens, CD8 Antigens, Leukocyte Common Antigens, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review